<mets:mets xmlns:mets="http://www.loc.gov/METS/" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xlink="http://www.w3.org/1999/xlink">
    <mets:dmdSec ID="DMD_1eb2253a-e73e-43ee-82c0-5b247e480cda">
        <mets:mdWrap MIMETYPE="text/xml" MDTYPE="MODS">
            <mets:xmlData>
                <mods xmlns="http://www.loc.gov/mods/v3" version="3.7" xmlns:vl="http://visuallibrary.net/vl">
                    <titleInfo lang="eng">
                        <title>Intellectual capital and competitive advantages</title>
                        <subTitle>the case of TTY Biopharm Company</subTitle>
                    </titleInfo>
                    <name type="personal">
                        <displayForm>Chen, Ming-Chin</displayForm>
                        <namePart type="given">Ming-Chin</namePart>
                        <namePart type="family">Chen</namePart>
                        <role>
                            <roleTerm type="code" authority="marcrelator">aut</roleTerm>
                        </role>
                    </name>
                    <typeOfResource>text</typeOfResource>
                    <genre authority="dini">article</genre>
                    <originInfo>
                        <dateIssued encoding="w3cdtf" keyDate="yes">2004</dateIssued>
                        <dateIssued encoding="w3cdtf">2005-08-01</dateIssued>
                        <dateOther encoding="w3cdtf" keyDate="yes">2007-10-25</dateOther>
                    </originInfo>
                    <language>
                        <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
                    </language>
                    <abstract lang="eng">By conducting indepth interviews with the CEO and top management of TTY Biopharm Company, a Taiwan-based pharmaceutical company, I depict the role of TTY’s intellectual capital in building competitive advantages and enhancing the achievement of corporate strategies. TTY’s success illustrates that even in a relatively small pharmaceutical market such as Taiwan, where a full-range new drug R&amp;D, covering from discovering new chemicals to developing new drugs, seems economically infeasible, adopting fit R&amp;D strategies and developing intellectual capital to establish competitive advantages can overcome the limitations in home market size and bear fruitful results.</abstract>
                    <note>Section &quot;Research Paper&quot;</note>
                    <classification authority="ddc">330</classification>
                    <relatedItem type="host">
                        <titleInfo>
                            <title>Journal of Business Chemistry</title>
                        </titleInfo>
                        <part>
                            <detail type="issue">
                                <number>Journal of Business Chemistry</number>
                            </detail>
                            <extent unit="page">
                                <start>14</start>
                                <end>20</end>
                            </extent>
                        </part>
                    </relatedItem>
                    <identifier type="urn">urn:nbn:de:hbz:6-45649598552</identifier>
                    <accessCondition type="use and reproduction" xlink:href="https://rightsstatements.org/vocab/InC/1.0/">Urheberrechtsschutz</accessCondition>
                    <recordInfo>
                        <recordIdentifier>muenster_miami_1eb2253a-e73e-43ee-82c0-5b247e480cda</recordIdentifier>
                    </recordInfo>
                    <extension>
                        <vl:doctype>oaArticle</vl:doctype>
                    </extension>
                </mods>
            </mets:xmlData>
        </mets:mdWrap>
    </mets:dmdSec>
    <mets:fileSec>
        <mets:fileGrp USE="pdf upload">
            <mets:file MIMETYPE="application/pdf" ID="FILE_1eb2253a-e73e-43ee-82c0-5b247e480cda_1">
                <mets:FLocat xlink:href="https://repositorium.uni-muenster.de/document/miami/1eb2253a-e73e-43ee-82c0-5b247e480cda/2004_vol1_iss1_14-20.pdf" LOCTYPE="URL"/>
            </mets:file>
        </mets:fileGrp>
    </mets:fileSec>
    <mets:structMap TYPE="LOGICAL">
        <mets:div TYPE="document" ID="muenster_miami_1eb2253a-e73e-43ee-82c0-5b247e480cda" DMDID="DMD_1eb2253a-e73e-43ee-82c0-5b247e480cda">
            <mets:fptr FILEID="FILE_1eb2253a-e73e-43ee-82c0-5b247e480cda_1"/>
        </mets:div>
    </mets:structMap>
</mets:mets>
